ALSUntangled No. 8: Low dose naltrexone for ALS

Amyotroph Lateral Scler. 2011 Jan;12(1):76-8. doi: 10.3109/17482968.2010.544386. Epub 2010 Dec 21.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / immunology
  • Dose-Response Relationship, Drug
  • Humans
  • Immune System / drug effects
  • Immunologic Factors / administration & dosage
  • Immunologic Factors / adverse effects
  • Immunologic Factors / pharmacology
  • Immunologic Factors / therapeutic use*
  • Internet
  • Naltrexone / administration & dosage
  • Naltrexone / adverse effects
  • Naltrexone / pharmacology
  • Naltrexone / therapeutic use*
  • Neuroimmunomodulation
  • Neuroprotective Agents / administration & dosage
  • Neuroprotective Agents / adverse effects
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use*

Substances

  • Immunologic Factors
  • Neuroprotective Agents
  • Naltrexone